Diabetes, Vol 44, Issue 2 156-160, Copyright © 1995 by American Diabetes Association

ARTICLES

Kinin, a mediator of diabetes-induced glomerular hyperfiltration

AA Jaffa, PF Rust and RK Mayfield
Department of Medicine, Medical University of South Carolina, Charleston 29425.

Renal kallikrein is increased in diabetic patients and streptozotocin (STZ)-induced diabetic rats with hyperfiltration. Chronic inhibition of renal kallikrein reduces glomerular filtration rate (GFR) and renal plasma flow (RPF) in hyperfiltering STZ-induced diabetic rats. To investigate whether these actions of kallikrein and its inhibition are kinin-mediated, we used a B2-kinin receptor antagonist (BKA). In STZ-induced diabetic rats with hyperfiltration, renal kallikrein excretion rate was significantly increased (P < or = 0.01), and kinin excretion rate was increased 57%, as compared with control rats. Left kidney GFR and RPF were measured before and during a 40-min infusion of BKA (0.5 micrograms.kg-1.min-1) or vehicle. Infusion of the kinin receptor antagonist reduced the GFR and RPF significantly. GFR was reduced by 18%, from an average baseline value of 2.07 +/- 0.11 to 1.70 +/- 0.06 ml/min, P < or = 0.001 (means +/- SE). RPF was reduced by 25%, from 6.74 +/- 0.38 to 5.06 +/- 0.17 ml/min, P < or = 0.001. Total renal vascular resistance was significantly increased during BKA infusion, P < or = 0.001. Vehicle infusion for the same period had no significant effect on GFR, RPF, or renal vascular resistance. These findings further support the hypothesis that increased renal production of kinins contributes to the renal vasodilation of diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Tan, J.-S. Keum, B. Wang, M. B. McHenry, S. R. Lipsitz, and A. A. Jaffa Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1026 - F1035. [Abstract] [Full Text] [PDF]

				J. Allard, M. Buleon, E. Cellier, I. Renaud, C. Pecher, F. Praddaude, M. Conti, I. Tack, and J.-P. Girolami ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1083 - F1092. [Abstract] [Full Text] [PDF]

				G. Yuan, J. Deng, T. Wang, C. Zhao, X. Xu, P. Wang, J. W. Voltz, M. L. Edin, X. Xiao, L. Chao, et al. Tissue Kallikrein Reverses Insulin Resistance and Attenuates Nephropathy in Diabetic Rats by Activation of Phosphatidylinositol 3-Kinase/Protein Kinase B and Adenosine 5'-Monophosphate-Activated Protein Kinase Signaling Pathways Endocrinology, May 1, 2007; 148(5): 2016 - 2026. [Abstract] [Full Text] [PDF]

				Y. Tan, B. Wang, J.-S. Keum, and A. A. Jaffa Mechanisms through which bradykinin promotes glomerular injury in diabetes Am J Physiol Renal Physiol, March 1, 2005; 288(3): F483 - F492. [Abstract] [Full Text] [PDF]

				A. A. Jaffa, R. Durazo-Arvizu, D. Zheng, D. T. Lackland, S. Srikanth, W. T. Garvey, and A. H. Schmaier Plasma Prekallikrein: A Risk Marker for Hypertension and Nephropathy in Type 1 Diabetes Diabetes, May 1, 2003; 52(5): 1215 - 1221. [Abstract] [Full Text] [PDF]

				W. Huang, Y. Gallois, N. Bouby, P. Bruneval, D. Heudes, M.-F. Belair, J. H. Krege, P. Meneton, M. Marre, O. Smithies, et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse PNAS, October 25, 2001; (2001) 231476798. [Abstract] [Full Text] [PDF]

				C. Tschope, A. Reinecke, U. Seidl, M. Yu, V. Gavriluk, U. Riester, P. Gohlke, K. Graf, M. Bader, U. Hilgenfeldt, et al. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2333 - H2340. [Abstract] [Full Text] [PDF]

				A. A. Jaffa, B. S. Miller, S. A. Rosenzweig, P. S. Naidu, V. Velarde, and R. K. Mayfield Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells Am J Physiol Renal Physiol, December 1, 1997; 273(6): F916 - F924. [Abstract] [Full Text] [PDF]

				W. R. Fitzgibbon, A. A. Jaffa, R. K. Mayfield, and D. W. Ploth Role of Kinins in the Renal Response to Enalaprilat in Normotensive and Hypertensive Rats Hypertension, February 1, 1996; 27(2): 235 - 244. [Abstract] [Full Text]

				W. Huang, Y. Gallois, N. Bouby, P. Bruneval, D. Heudes, M.-F. Belair, J. H. Krege, P. Meneton, M. Marre, O. Smithies, et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse PNAS, November 6, 2001; 98(23): 13330 - 13334. [Abstract] [Full Text] [PDF]